Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
ARRY [NASD]
Array BioPharma, Inc.
Index- P/E- EPS (ttm)-0.60 Insider Own5.84% Shs Outstand125.46M Perf Week1.07%
Market Cap474.24M Forward P/E- EPS next Y-0.65 Insider Trans-0.16% Shs Float119.42M Perf Month-27.03%
Income-71.30M PEG- EPS next Q-0.21 Inst Own92.60% Short Float12.26% Perf Quarter-31.27%
Sales63.70M P/S7.44 EPS this Y-72.70% Inst Trans-0.01% Short Ratio9.69 Perf Half Y-30.51%
Book/sh-0.04 P/B- EPS next Y5.80% ROA-52.70% Target Price7.50 Perf Year-36.58%
Cash/sh0.95 P/C3.96 EPS next 5Y10.00% ROE307.40% 52W Range3.39 - 7.10 Perf YTD-24.55%
Dividend- P/FCF- EPS past 5Y22.50% ROI-65.80% 52W High-47.89% Beta1.96
Dividend %- Quick Ratio3.40 Sales past 5Y19.30% Gross Margin38.10% 52W Low9.14% ATR0.28
Employees265 Current Ratio3.40 Sales Q/Q-58.80% Oper. Margin-78.20% RSI (14)31.26 Volatility7.45% 7.10%
OptionableYes Debt/Eq- EPS Q/Q35.00% Profit Margin- Rel Volume0.84 Prev Close3.78
ShortableYes LT Debt/Eq- EarningsMay 05 Payout- Avg Volume1.51M Price3.70
Recom1.50 SMA20-13.16% SMA50-21.73% SMA200-31.31% Volume637,377 Change-2.12%
09-Aug-13Reiterated Stifel Buy $7 → $8
23-Jul-10Upgrade UBS Neutral → Buy $4.25
22-Apr-10Downgrade UBS Buy → Neutral
05-Nov-09Upgrade UBS Neutral → Buy
08-Sep-09Downgrade UBS Buy → Neutral
04-Sep-09Downgrade Robert W. Baird Outperform → Neutral $10 → $3
04-Sep-09Downgrade Leerink Swann Outperform → Mkt Perform $6 → $2
04-Sep-09Downgrade Boenning & Scattergood Outperform → Neutral
17-Jun-09Initiated Boenning & Scattergood Outperform $6
07-May-08Reiterated Rodman & Renshaw Mkt Outperform $18 → $15
07-Feb-08Initiated William Blair Outperform
20-Dec-07Reiterated Collins Stewart Buy $17 → $16
04-Dec-07Initiated Morgan Joseph Buy $16
07-Nov-07Reiterated Collins Stewart Buy $20 → $17
09-Oct-07Initiated Lehman Brothers Overweight $16
13-Aug-07Initiated Rodman & Renshaw Mkt Outperform $18
23-May-07Initiated JP Morgan Overweight
04-Jan-07Reiterated Piper Jaffray Outperform $14 → $20
27-Mar-14 02:20PM  Array BioPharma: A Biotech With Many Shots On Goal at Seeking Alpha
05-Mar-14 01:13PM  Price Movements, Clinical Trial Results, and Solid Financial Reports - Analyst Notes on Pfizer, Dendreon, DepoMed, Globus Medical, and Array PR Newswire
03-Mar-14 08:39AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
08:00AM  Array BioPharma Provides Clinical Update On ARRY-502 For Asthma At Scientific Meeting PR Newswire
26-Feb-14 04:26PM  [video] Array CEO: Partnerships Smart While Cancer Drug Develops at TheStreet
04:26PM  [video] Array CEO: Partnerships Smart While Cancer Drug Develops
20-Feb-14 11:30AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
18-Feb-14 12:45PM  Array BioPharma To Present At The RBC Capital Markets Global Healthcare And Cowen Annual Healthcare Conferences PR Newswire
11-Feb-14 01:04PM  ARRAY BIOPHARMA INC Financials EDGAR Online Financials
07-Feb-14 08:15AM  Eight Biotech Stocks Trading Near $5 With Huge Upside Potential at 24/7 Wall St.
08:15AM  Eight Biotech Stocks Trading Near $5 With Huge Upside Potential
06-Feb-14 04:30PM  Array BioPharma To Present At The Leerink Swann Global Healthcare Conference PR Newswire
05-Feb-14 04:56PM  ARRAY BIOPHARMA INC Files SEC form 10-Q, Quarterly Report EDGAR Online
04-Feb-14 04:03PM  Array BioPharma's CEO Discusses F2Q14 Results - Earnings Call Transcript at Seeking Alpha
04:03PM  Array BioPharma's CEO Discusses F2Q14 Results - Earnings Call Transcript
12:43PM  Why Array Biopharma Inc. Shares (Briefly) Popped at Motley Fool
09:00AM  Array BioPharma Inc. Earnings Call scheduled for 9:00 am ET today CCBN
08:49AM  Array BioPharma Inc. Earnings Call scheduled for 9:00 am ET today CCBN
08:07AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statem EDGAR Online
08:00AM  Array BioPharma Reports Financial Results For The Second Quarter Of Fiscal 2014 PR Newswire
07:34AM  Array BioPharma Inc. Earnings Call scheduled for 9:00 am ET today CCBN
03-Feb-14 10:43AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online -6.03%
07:07AM  Q2 2014 Array BioPharma Inc. Earnings Release - After Market Close CCBN
07:07AM  Q2 2014 Array BioPharma Inc. Earnings Release - After Market Close
29-Jan-14 11:00AM  Array BioPharma to Report Financial Results for the Second Quarter of Fiscal 2014 on February 4, 2014 PR Newswire -5.74%
11:00AM  Array BioPharma to Report Financial Results for the Second Quarter of Fiscal 2014 on February 4, 2014
15-Jan-14 01:09PM  Array BioPharma's CEO Presents at JPMorgan Healthcare Conference (Transcript) at Seeking Alpha
01:09PM  Array BioPharma's CEO Presents at JPMorgan Healthcare Conference (Transcript)
03-Jan-14 01:30PM  Array BioPharma To Present At The Annual J.P. Morgan Healthcare Conference PR Newswire
01:30PM  Array BioPharma To Present At The Annual J.P. Morgan Healthcare Conference
31-Dec-13 04:18PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online
04:18PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement
27-Dec-13 04:04PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
04:04PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Change in Directors or Principal Officers
14-Dec-13 08:15AM  3 Horrendous Health-Care Stocks This Week at Motley Fool
08:15AM  3 Horrendous Health-Care Stocks This Week
12-Dec-13 03:16AM  Array gets a big vote of confidence optionMONSTER
03:16AM  Array gets a big vote of confidence
11-Dec-13 06:22PM  Nasdaq stocks posting largest percentage decreases AP
01:30PM  Nasdaq stocks posting largest percentage decreases AP
10-Dec-13 05:59PM  Nasdaq stocks posting largest percentage decreases AP
01:56PM  Nasdaq stocks posting largest percentage decreases AP
09-Dec-13 08:32PM  Why Array BioPharma, Genie Energy, and Hanwha SolarOne Tumbled Today at Motley Fool -12.54%
08:32PM  Why Array BioPharma, Genie Energy, and Hanwha SolarOne Tumbled Today
06:03PM  Nasdaq stocks posting largest percentage decreases AP
01:33PM  Nasdaq stocks posting largest percentage decreases AP
12:06PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
12:06PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
12:04PM  Array says ARRY-614 data shows pronounced platelet effect in some patients theflyonthewall.com
12:04PM  Array says ARRY-614 data shows pronounced platelet effect in some patients
12:00PM  Array BioPharma Provides Clinical Update On ARRY-614 For Myelodysplastic Syndromes At The 2013 American Society Of Hematology Meeting PR Newswire
12:00PM  Array BioPharma Provides Clinical Update On ARRY-614 For Myelodysplastic Syndromes At The 2013 American Society Of Hematology Meeting
08:30AM  Array BioPharma Provides Clinical Update On Filanesib (ARRY-520) For Multiple Myeloma At The 2013 American Society of Hematology Meeting PR Newswire
08:30AM  Array BioPharma Provides Clinical Update On Filanesib (ARRY-520) For Multiple Myeloma At The 2013 American Society of Hematology Meeting
03-Dec-13 09:31PM  Array BioPharma's CEO Presents at Piper Jaffray Healthcare Conference (Transcript) at Seeking Alpha
02-Dec-13 06:03PM  Nasdaq stocks posting largest percentage increases AP
03:47PM  Nasdaq stocks posting largest percentage increases AP
29-Nov-13 05:54PM  Nasdaq stocks posting largest percentage increases AP +9.58%
23-Nov-13 04:05PM  Opportunities in Lung Cancer Therapies at Motley Fool
21-Nov-13 08:05AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
08:04AM  InPlay: Array Biopharma announces that Kevin Koch, President and Chief Scientific Officer, will be leaving Array to pursue other opportunities Briefing.com
08:00AM  Array BioPharma Announces Management Team Change PR Newswire
20-Nov-13 10:00AM  Array BioPharma's CEO Presents at Jefferies 2013 Global Healthcare Conference (Transcript) at Seeking Alpha
11-Nov-13 06:10PM  Array BioPharma To Present At The Jefferies 2013 Global Healthcare And Piper Jaffray 25th Annual Healthcare Conferences PR Newswire
07-Nov-13 01:04PM  ARRAY BIOPHARMA INC Financials EDGAR Online Financials
09:10AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
09:00AM  Array BioPharma To Present Clinical Data At The 2013 ASH Annual Meeting On ARRY-520 For Multiple Myeloma And ARRY-614 For Myelodysplastic Syndromes PR Newswire
04-Nov-13 03:50AM  Zacks #1 Rank Additions for Monday Zacks +7.99%
01-Nov-13 04:21PM  ARRAY BIOPHARMA INC Files SEC form 10-Q, Quarterly Report EDGAR Online
31-Oct-13 10:20PM  Array BioPharma's CEO Discusses F1Q 2014 Results - Earnings Call Transcript at Seeking Alpha
09:00AM  Array BioPharma Inc. Earnings Call scheduled for 9:00 am ET today CCBN
08:55AM  Array BioPharma Inc. Discusses Q1 2014 Results (Webcast) at Seeking Alpha
08:50AM  Array BioPharma Inc. Earnings Call scheduled for 9:00 am ET today CCBN
07:36AM  Array BioPharma Inc. Earnings Call scheduled for 9:00 am ET today CCBN
07:09AM  InPlay: Array Biopharma beats by $0.05, beats on revs Briefing.com
07:07AM  Q1 2014 Array BioPharma Inc. Earnings Release - After Market Close CCBN
07:05AM  Array Biopharma Outlines Path To Market For New Myeloma Drug at Forbes
07:02AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib EDGAR Online
07:00AM  Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2014 And Announces ARRY-520 Development Strategy PR Newswire
30-Oct-13 04:36PM  ARRY Crosses Below Key Moving Average Level at Forbes -6.93%
28-Oct-13 04:40PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
02:24PM  Array BioPharma To Report Financial Results For The First Quarter Of Fiscal 2014 On October 31, 2013 PR Newswire
22-Oct-13 06:23AM  InPlay: Array Biopharma: AstraZenica (AZN) initiates Phase 3 clinical trial for selumetinib in non-small cell lung cancer; triggers $3 mln milestone payment to Array Briefing.com
06:05AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
06:00AM  AstraZeneca Initiates Phase 3 Clinical Trial For Selumetinib In Non-Small Cell Lung Cancer PR Newswire
14-Oct-13 08:15AM  Jefferies Top Biotech Stocks to Buy 24/7 Wall St.
08-Oct-13 04:10PM  Data on Oncothyreon's ONT-380 Zacks -9.11%
07-Oct-13 02:56PM  Array BioPharma Needs a Partner to Take It to the Next Level at Motley Fool
01-Oct-13 09:55AM  Insiders at Copart and The Marcus Corporation Buy Shares While Masonite International Sees a Sale at Minyanville
09:04AM  Nike Inc EVP Sells 66K Shares and 4 Insider Sales to Note at Wall St. Cheat Sheet
30-Sep-13 03:06PM  More Important Than "Shots on Goal" at Motley Fool
09:28AM  Jim Cramer: Buy Dunkin Brands, GameStop, and 2 More Stock Picks at Wall St. Cheat Sheet
28-Sep-13 06:00AM  Jim Cramer's Top Stock Picks: DNKN PCYC ARRY GME at TheStreet
27-Sep-13 08:07PM  Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan at TheStreet
06:50PM  [video] Array Biopharma CEO: Developing products ourselves at CNBC
24-Sep-13 02:14PM  Array BioPharma to Present at the NewsMakers in the Biotech Industry Conference PR Newswire
19-Sep-13 10:58AM  Ted Tenthoff, Managing Director and Senior Research Analyst at Piper Jaffray & Co., Interviews with The Wall Street Transcript: Increased Biotech Productivity and Innovation Reflected in FDA-Approved Drugs Wall Street Transcript
17-Sep-13 09:50AM  Insiders Buy Shares at Home Depot and PBF Energy at Minyanville
09:43AM  Array BioPharma Director Sells 546K Shares and 4 Insider Sales to Note at Wall St. Cheat Sheet
12:15AM  [$$] Patients Share DNA for Cures at The Wall Street Journal
Array BioPharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases primarily in North America, Europe, and the Asia Pacific. Its proprietary clinical programs include ARRY-520, a kinesin spindle protein inhibitor, which is in Phase 2 clinical trial for patients with multiple myeloma; ARRY-614, a p38/Tie2 dual inhibitor that is in Phase 1 clinical trial for the treatment of myelodysplastic syndromes; ARRY-797, a p38 inhibitor, which is in Phase 2 clinical trial for pain; and ARRY-502, a CRTh2 antagonist that is in Phase 2 clinical trial for asthma. The company's partnered clinical programs comprise drug candidates for the treatment of cancer, including MEK162, an MEK inhibitor in Phase 3 clinical trial; Selumetinib, an MEK inhibitor in Phase 2/pivotal clinical trial; and GDC-0068 AKT inhibitor, LY2606368 Chk-1 inhibitor, and VTX-2337 toll-like receptor in Phase 2 clinical trial. Its partnered clinical programs also include Danoprevir, a Hepatitis C virus protease inhibitor in Phase 2 clinical trial; ARRY-543/ASLAN001, a HER2/EGFR inhibitor for gastric cancer in Phase 2 clinical trial; GDC-0575 and GDC-0425 Chk-1 inhibitors for cancer in Phase 1b clinical trial; ARRY-380, an HER2 inhibitor in Phase 1 clinical trial for breast cancer; and GDC-0994 in a Phase 1 dose-escalation study in patients with locally advanced or metastatic solid tumors. The company has collaborations with Amgen Inc.; ASLAN Pharmaceuticals Pte Ltd.; AstraZeneca, PLC; Celgene Corporation; Eli Lilly and Company; Genentech Inc.; Novartis International Pharmaceutical Ltd.; Oncothyreon Inc.; and VentiRx Pharmaceuticals, Inc. for the development and commercialization of the partnered drugs. Array BioPharma Inc. was founded in 1998 and is headquartered in Boulder, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MOORE JOHN RVP, General CounselNov 29Sale5.7911,66667,54620Dec 03 04:34 PM
MOORE JOHN RVP, General CounselNov 13Sale5.792001,15811,686Nov 15 05:22 PM
Ratcliffe LiamDirectorSep 27Sale5.99863,5215,170,7640Sep 30 05:46 PM
Ratcliffe LiamDirectorSep 26Sale6.02262,2071,578,958863,521Sep 30 05:46 PM
Ratcliffe LiamDirectorSep 16Sale6.14319,0331,957,6501,125,728Sep 16 05:48 PM
Ratcliffe LiamDirectorSep 13Sale6.01546,6603,287,6681,444,761Sep 16 05:48 PM
Ratcliffe LiamDirectorSep 12Sale6.10807,4794,923,1191,991,421Sep 16 05:48 PM
Ratcliffe LiamDirectorSep 06Sale5.68139,572793,2022,798,900Sep 06 05:10 PM
Ratcliffe LiamDirectorSep 05Sale5.77201,5981,163,5232,938,472Sep 06 05:10 PM
Ratcliffe LiamDirectorSep 04Sale5.87236,1161,385,6233,140,070Sep 06 05:10 PM
MOORE JOHN RVP, General CounselAug 02Option Exercise3.0443,884133,59155,770Aug 02 06:24 PM
MOORE JOHN RVP, General CounselAug 02Sale7.0343,884308,46911,886Aug 02 06:24 PM
MOORE JOHN RVP, General CounselAug 01Option Exercise2.8826,74177,11543,386Aug 02 06:24 PM
MOORE JOHN RVP, General CounselAug 01Sale7.0031,500220,63511,886Aug 02 06:24 PM
MOORE JOHN RVP, General CounselJul 25Option Exercise3.754,75917,84616,645Jul 25 07:42 PM
SNITMAN DAVIDCOO and VP, Business Devel.Jul 24Option Exercise3.7521,35780,0891,517,509Jul 25 07:49 PM
KOCH KEVINPresident, CSOJul 24Option Exercise3.7522,28683,573797,240Jul 25 07:47 PM
CARRUTHERS MICHAELCFOJul 24Option Exercise3.7515,32157,454123,134Jul 25 07:45 PM
MOORE JOHN RVP, General CounselJul 23Option Exercise2.745,00013,70016,886Jul 25 07:42 PM
MOORE JOHN RVP, General CounselJul 23Sale6.505,00032,50011,886Jul 25 07:42 PM